National On-Site Drug Testing Laboratory
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
AOUSC-PROCUREMENT MANAGEMENT DIV
Contract Value
Not provided
Codes & Classification
Solicitation Number
USCA25R0183
NAICS
541380 - Testing Laboratories and Services
Classification Code
Q301
Additional Details
The Administrative Office of the U.S. Courts (AO), through its Procurement Management Division, has issued a solicitation (Procurement Identifier: USCA25R0183) for the provision of National On-Site Drug Testing Laboratory services. This procurement seeks to establish an indefinite delivery, indefinite quantity (IDIQ) contract to support the United States Probation and Pretrial Services Offices (USPPSO) with comprehensive on-site urine drug testing capabilities.
The primary objective of this solicitation is to secure a contractor capable of supplying, installing, and maintaining all necessary equipment, reagents, consumables, and supplies required to operate instrumented screening urine testing facilities. In addition to the physical components, the contractor will be responsible for providing a robust data management program and delivering training to ensure the effective operation of these laboratories. The scope of services extends to supporting USPPSO and its district on-site laboratories across the contiguous United States, as well as Alaska, Hawaii, Puerto Rico, Guam, and the Virgin Islands, ensuring nationwide coverage for the judiciary’s drug testing needs.
This opportunity is classified under NAICS code 541380 (Testing Laboratories and Services) and Product Service Code Q301, reflecting its focus on laboratory testing services. The place of performance is designated as Washington, District of Columbia, though the contract’s reach encompasses all specified U.S. territories and states where USPPSO operates on-site laboratories.
The solicitation is unrestricted, meaning it is open to all qualified vendors and is not set aside for small businesses. Notably, the procurement is governed by the Judiciary Guide Volume 14, § 330 Standard Competitive Contracting Procedures, rather than the Federal Acquisition Regulation (FAR), and is therefore not subject to small business regulations typically associated with federal procurements.
Interested contractors are directed to review the attached solicitation document (USCA25R0183) and its amendments, which provide comprehensive details on the requirements, proposal preparation instructions, and the evaluation criteria that will be used to assess submissions. Amendment 0001, including Attachment 5, addresses responses to vendor questions and contains a revised Request for Proposals (RFP).
The contracting entity for this procurement is the AOUSC Procurement Management Division, a federal office based in Washington, DC. For further information or clarification, prospective offerors may contact AJ Lee ([email protected]) or Vanessa Jackson ([email protected]).
This solicitation represents a significant opportunity for organizations with expertise in laboratory testing services, particularly those with the capacity to deliver turnkey solutions for on-site drug testing, data management, and training across a broad geographic area. Contractors should carefully assess their ability to meet the technical, logistical, and operational requirements outlined in the solicitation documents to determine alignment with their capabilities and strategic objectives.
Documents7